跳到主要內容

Greenleaf Peter 的 Form 4 申報

Pelthos Therapeutics Inc.(PTHS),2026/7/7 申報

申報編號
0001919246-26-000100
申報時間
2026/7/7 17:03 ET
交易日
2026/7/2
申報延遲
5 天
10b5-1 計畫
有勾選

這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $2.08 萬。交易後 5 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Greenleaf PeterCIK 0001363683董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/7/2Common StockS賣出處分−712$26.00F2−$18,508.7223,969直接
2026/7/2Common StockS賣出處分−85$27.27F3−$2,318.2323,884直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $25.58 to $26.53. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)